Results
eNauka >
Rezultati >
1-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer
| Naziv: | 1-year follow-up of a phase III study to compare efficacy and safety of a bevacizumab biosimilar, CT-P16, and reference bevacizumab as first-line treatment for metastatic or recurrent non-squamous non-small cell lung cancer | Autori  : | Verschraegen, Claire; Andric, Zoran G   ; ...; (broj, koautora 20) |
Godina: | 2022 | Publikacija: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Pretraži identifikator |
Tip rezultata: | Konferencijski rad | Kolacija: | vol. 33 br. 7 str. S1024-S1025 | DOI: | 10.1016/j.annonc.2022.07.1153 | WoS-ID: | 000866211601292 | URI: | https://enauka.gov.rs/handle/123456789/823166 | Projekat: | Celltrion Inc. | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.